AI-Enhanced Diabetes Foot Ulcer Monitor Market Report 2026

The artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market size has grown rapidly in recent years. It will grow from $1.71 billion in 2025 to $2.03 billion in 2026 at a compound annual growth rate (CAGR) of 18.5%. The growth in the historic period can be attributed to increasing diabetes prevalence worldwide, rising incidence of diabetic foot complications, expansion of telehealth monitoring solutions, growing clinical focus on preventive wound care, improvements in medical imaging technologies.

The artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market size is expected to see rapid growth in the next few years. It will grow to $3.96 billion in 2030 at a compound annual growth rate (CAGR) of 18.3%. The growth in the forecast period can be attributed to increasing adoption of ai-powered diagnostic tools, rising demand for homecare monitoring solutions, expansion of predictive healthcare analytics, growing integration of imaging and sensor technologies, increasing emphasis on preventive diabetic care. Major trends in the forecast period include increasing adoption of AI-based foot ulcer risk assessment, rising use of computer vision for wound analysis, growing deployment of smart wearable foot sensors, expansion of home-based diabetic foot monitoring, enhanced focus on early ulcer detection.

The increasing healthcare expenditure is expected to drive the growth of the artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market in the coming years. Healthcare expenditure refers to the total spending by individuals, institutions, and governments on services and activities aimed at maintaining or improving health. This expenditure is rising due to the growing prevalence of chronic diseases, which increases the demand for continuous medical care, long-term treatments, and management resources. Higher healthcare spending enables hospitals and clinics to adopt AI-enhanced diabetes foot ulcer monitors, which improve patient management and reduce long-term treatment costs. For example, in April 2025, the Office for National Statistics, a UK government agency, reported that government-funded healthcare accounted for the majority of healthcare spending in the UK, reaching $344 billion (£258 billion) in 2024, a 2.5% increase in real terms compared to 2023. Consequently, growing healthcare expenditure is fueling the expansion of the AI-enhanced diabetes foot ulcer monitor market.

Key companies in the AI-enhanced diabetes foot ulcer monitor market are focusing on securing funding to scale production, expand market reach, and improve patient accessibility. Funding refers to sums of money set aside or pooled for specific purposes, investments, or expenditures. For instance, in July 2024, IR-MED Inc., an Israel-based medical device developer, announced a $500,000 grant to support the development of its device for early detection of diabetic foot ulcers. With this funding, IR-MED can advance the development and commercialization of its AI-enhanced DiaSafe device for diabetes foot ulcer monitoring in the second half of 2025 through a 13-month program. The DiaSafe device, built on the PressureSafe platform launching in late 2024, integrates AI-driven data analysis with infrared sensing to detect diabetic foot ulcers early. This technology can reveal conditions that may not be visible to the naked eye, particularly in patients with darker skin tones. Additionally, the platform’s AI-powered decision support system evaluates bioinformation against condition-specific biomarker profiles to determine whether tissue is healthy or at risk.

In June 2023, Swift Medical, a Canada-based digital health technology company, partnered with the American Podiatric Medical Association (APMA) to improve care for diabetic foot ulcers and chronic wounds. This collaboration is expected to enhance patient care significantly. By integrating AI-powered technology, the partnership aims to enable more accurate assessments and better treatment outcomes. The APMA is a US-based professional organization focused on podiatric health.

Major companies operating in the artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market are Net Health Systems Inc., Podimetrics Inc., Orpyx Medical Technologies Inc., Spectral AI Inc., Siren Care Inc., Calceus Health Pty Ltd., WoundVision LLC., Bluedrop Medical Inc., Moticon GmbH., eKare Inc., Sensoria Health Inc., Baliston Limited., Empo Health Inc., MolecuLight Inc., MIMOSA Diagnostics Inc., Thermology Health Ltd., IR-MED Inc., DiabSense Private Limited, HeloCare Inc., SmartDiabetes Tech Ltd.

North America was the largest region in the artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the AI-enhanced diabetes foot ulcer monitor market by increasing costs of imported imaging systems, smart sensors, wearable components, and semiconductor-based analytics hardware. Healthcare providers in North America and Europe are most affected due to dependence on imported diagnostic devices, while Asia-Pacific faces higher production costs for sensor-based monitoring systems. These tariffs are increasing system prices and limiting adoption among smaller clinics and homecare providers. However, they are also encouraging domestic manufacturing of wearable devices, regional software innovation, and localized supply chains for diabetic monitoring technologies.

The artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market research report is one of a series of new reports that provides artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market statistics, including artificial intelligence (AI)-enhanced diabetes foot ulcer monitor industry global market size, regional shares, competitors with a artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market share, detailed artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced diabetes foot ulcer monitor industry. This artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

An artificial intelligence (AI)-enhanced diabetes foot ulcer monitor is a specialized medical system that uses AI algorithms to assess and monitor foot health in people with diabetes. It leverages intelligent data analysis and image interpretation to detect early signs of existing or developing ulcers, enabling continuous and accurate evaluation of foot conditions.

The main product types of AI-enhanced diabetes foot ulcer monitors include wearable devices, non-wearable devices, smart sensors, and imaging systems. Wearable devices are portable, body-mounted technologies that continuously track physiological signals and health indicators. These systems employ technologies such as machine learning, deep learning, computer vision, and others. They are applied in hospitals and clinics, homecare, ambulatory surgical centers, research institutes, and more. End-users include healthcare providers, patients, research organizations, and others, with distribution through both online and offline channels.

The artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market consists of revenues earned by entities by providing services such as image‐based wound detection, wearable sensor monitoring, remote monitoring, treatment adherence tracking, and predictive healing assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced diabetes foot ulcer monitor market also includes sales of pressure-mapping mats, thermal imaging scanners, wound-imaging cameras, and multispectral imaging devices. values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.